Continence Rate and Oncological Feasibility after Total Transurethral Resection of the Prostate as an Alternative Therapy for the Treatment of Prostate Cancer: A Pilot Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The value of total transurethral resection of prostate cancer (TURPC) as an alternative therapy was first recognized by Hans J. Reuter. Thus, we conducted the study of prospectively collected data to verify total TURPC as an alternative therapy forlocalized prostate cancer. Methods: From January 2008 to July 2011, 14 patients with a mean age of 76.1 years (range, 66 to 89 years) with clinically localized prostate cancer were treated by prostatic resection by the corresponding author with curative intention. Results: The mean duration of TURPC was 51.7 minutes (range, 30 to 120 minutes) and the mean amount of prostatic tissue resected was 21.2 g (range, 5 to 66 g). An intra- and/or postoperative blood transfusion was necessary in 2 cases. Hyponatremia was found in 7 patients. Six months after TURPC, 3 cases of grade 1 and 1 case of grade 2 incontinence were observed. Three patients in the high-risk group did not achieve a prostate specific antigen (PSA) nadir of ≤0.2 ng/mL. PSA recurrence occurred in one case in our series. Newly developed lymph node or distant metastases were not observed during the follow-up period. Conclusions: According to our results, transurethral resection for prostate cancer can be performed with reasonable oncological results. The PSA nadir levels, and rates of biochemical failure and postoperative complications, including incontinence, were comparable with the published results for other procedures. TURPC is also inexpensive and non-invasive, and requires short hospitalization and a short surgical time without vesicourethral anastomosis.
Abstract
Purpose: The value of total transurethral resection of prostate cancer (TURPC) as an alternative therapy was first recognized by Hans J. Reuter. Thus, we conducted the study of prospectively collected data to verify total TURPC as an alternative therapy forlocalized prostate cancer. Methods: From January 2008 to July 2011, 14 patients with a mean age of 76.1 years (range, 66 to 89 years) with clinically localized prostate cancer were treated by prostatic resection by the corresponding author with curative intention. Results: The mean duration of TURPC was 51.7 minutes (range, 30 to 120 minutes) and the mean amount of prostatic tissue resected was 21.2 g (range, 5 to 66 g). An intra- and/or postoperative blood transfusion was necessary in 2 cases. Hyponatremia was found in 7 patients. Six months after TURPC, 3 cases of grade 1 and 1 case of grade 2 incontinence were observed. Three patients in the high-risk group did not achieve a prostate specific antigen (PSA) nadir of ≤0.2 ng/mL. PSA recurrence occurred in one case in our series. Newly developed lymph node or distant metastases were not observed during the follow-up period. Conclusions: According to our results, transurethral resection for prostate cancer can be performed with reasonable oncological results. The PSA nadir levels, and rates of biochemical failure and postoperative complications, including incontinence, were comparable with the published results for other procedures. TURPC is also inexpensive and non-invasive, and requires short hospitalization and a short surgical time without vesicourethral anastomosis.
참고문헌 (30)
- Aus G, "Current status of HIFU and cryotherapy in prostate cancer--a review", Eur Urol, 50, pp.927~934 (2006)
- Vallancien G, "Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study", J Urol, 171(6 Pt 1), pp.2265~2267 (2004)
- Poissonnier L, "Control of prostate cancer by transrectal HIFU in 227 patients", Eur Urol, 51, pp.381~387 (2007)
- Blana A, "Eight years’ experience with high-intensity focused ultrasonography for treatment of localized prostate cancer", Urology, 72, pp.1329~1333 (2008)
- Babaian RJ, "Best practice statement on cryosurgery for the treatment of localized prostate cancer", J Urol, 180, pp.1993~2004 (2008)
- Pisters LL, "Salvage prostate cryoablation: initial results from the cryo on-line data registry", J Urol, 180, pp.559~563 (2008)
- 박동수, "저위험군 및 중간위험군 국소 전립선암의 저선량 근접치료", Korean Journal of Urology, 50(7), pp.656~662 (2009), 대한비뇨기과학회
- Shipley WU, "Treatment of early stage prostate cancer in Comprehensive textbook of genitourinary oncology. 3rd ed", pp.153~157 (2006), Philadelphia: Lippincott Williams & Wilkins
- Cookson MS, "Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes", J Urol, 177, pp.540~545 (2007)
- Lange PH, "The value of serum prostate specific antigen determinations before and after radical prostatectomy", J Urol, 141, pp.873~879 (1989)
- Reuter MA, "Transurethral resection in prostate cancer, a radical procedure. Experience with 1017 cases", Arch Esp Urol, 61, pp.13~26 (2008)
- Reuter MA, "Radical transurethral resection of the prostate. An alternative therapy for the treatment of prostate cancer", Urologe A, 48, pp.740~747 (2009)
- Eggener SE, "Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities", J Urol, 178, pp.2260~2267 (2007)
- Rassweiler J, "Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention", Eur Urol, 50, pp.969~979 (2006)
- Michielsen DP, "Bipolar transurethral resection in saline--an alternative surgical treatment for bladder outlet obstruction", J Urol, 178, pp.2035~2039 (2007)
- Han M, "Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer", J Urol, 166, pp.416~419 (2001)
- Roehl KA, "Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results", J Urol, 172, pp.910~914 (2004)
- Berglund RK, "Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE", J Urol, 177, pp.526~529 (2007)
- Tewari A, "Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach", J Urol, 177, pp.911~915 (2007)
- Boorjian SA, "Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer", Cancer, 117, pp.2883~2891 (2011)
- Walsh PC, "Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate", J Urol, 163, pp.1802~1807 (2000)
- Kao TC, "Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy", J Urol, 163, pp.858~864 (2000)
- Penson DF, "5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study", J Urol, 179(5 Suppl), pp.S40~S44 (2008)
- Penson DF, "Prostate cancer: epidemiology and health-related quality of life", Urology, 72(6 Suppl), pp.S3~S11 (2008)
- Poulakis V, "Laparoscopic radical prostatectomy in men older than 70 years of age with localized prostate cancer: comparison of morbidity, reconvalescence, and short-term clinical outcomes between younger and older men", Eur Urol, 51, pp.1341~1348 (2007)
- Rassweiler J, "Laparoscopic radical prostatectomy with the Heilbronn technique: oncological results in the first 500 patients", J Urol, 173, pp.761~764 (2005)
- Trabulsi EJ, "Laparoscopic radical prostatectomy", J Urol, 173, pp.1072~1079 (2005)
- Rassweiler J, "Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group", Eur Urol, 49, pp.113~119 (2006)
- Berryhill R Jr, "Robotic prostatectomy: a review of outcomes compared with laparoscopic and open approaches", Urology, 72, pp.15~23 (2008)
- Secin FP, "Is it necessary to remove the seminal vesicles completely at radical prostatectomy? Decision curve analysis of European Society of Urologic Oncology criteria", J Urol, 181, pp.609~613 (2009)